Technical Analysis for RGEN - Repligen Corporation

Grade Last Price % Change Price Change
grade B 58.91 -4.61% -2.85
RGEN closed down 4.61 percent on Friday, March 22, 2019, on 1.25 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical RGEN trend table...

Date Alert Name Type % Chg
Mar 22 Fell Below 20 DMA Bearish 0.00%
Mar 22 Multiple of Ten Bearish Other 0.00%
Mar 21 20 DMA Support Bullish -4.61%
Mar 21 Pocket Pivot Bullish Swing Setup -4.61%
Mar 21 Multiple of Ten Bullish Other -4.61%
Mar 20 20 DMA Support Bullish -0.96%
Mar 20 Pocket Pivot Bullish Swing Setup -0.96%
Mar 20 Multiple of Ten Bearish Other -0.96%
Mar 19 20 DMA Support Bullish -0.77%
Mar 19 Doji - Bullish? Reversal -0.77%

Older signals for RGEN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Repligen Corporation, a life sciences company, engages in the development, production, and commercialization of consumable products used in the process of manufacturing biological drugs. Its bioprocessing products are sold to various life sciences and biopharmaceutical companies worldwide. The company manufactures Protein A, a critical reagent used to separate and purify monoclonal antibody therapeutics. It also supplies various growth factor products used to increase cell culture productivity during the fermentation stage of drug manufacturing. In addition, the company develops and markets its OPUS brand series of pre-packed ‘plug-and-play' chromatography columns, and provides ELISA test kits to ensure final product quality. Further, Repligen has a portfolio of clinical-stage partnering assets, including a pancreatic imaging agent in Phase 3 development and a orphan drug candidate in Phase 1 development. The company was founded in 1981 and is headquartered in Waltham, Massachusetts.
Biotechnology Biopharmaceutical Life Sciences Natural Sciences Consumable Products Monoclonal Antibody Bioprocessing
Is RGEN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 70.5
52 Week Low 34.05
Average Volume 286,745
200-Day Moving Average 54.8658
50-Day Moving Average 57.9846
20-Day Moving Average 59.234
10-Day Moving Average 59.574
Average True Range 1.9203
ADX 15.01
+DI 25.3426
-DI 14.5827
Chandelier Exit (Long, 3 ATRs ) 57.6491
Chandelier Exit (Short, 3 ATRs ) 61.3209
Upper Bollinger Band 62.1859
Lower Bollinger Band 56.2821
Percent B (%b) 0.45
BandWidth 9.966911
MACD Line 0.4785
MACD Signal Line 0.4339
MACD Histogram 0.0447
Fundamentals Value
Market Cap 2.19 Billion
Num Shares 37.3 Million
EPS 0.51
Price-to-Earnings (P/E) Ratio 115.51
Price-to-Sales 12.40
Price-to-Book 6.72
PEG Ratio 2.55
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 62.81
Resistance 3 (R3) 63.24 62.38 62.16
Resistance 2 (R2) 62.38 61.38 62.16 61.94
Resistance 1 (R1) 60.64 60.77 60.21 60.21 61.73
Pivot Point 59.78 59.78 59.56 59.56 59.78
Support 1 (S1) 58.04 58.78 57.61 57.61 56.09
Support 2 (S2) 57.18 58.17 56.96 55.88
Support 3 (S3) 55.44 57.18 55.66
Support 4 (S4) 55.01